Atlas Trials

Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis

Clinical trial NCT00080223 · COMPLETED

Trial details

NCT number
NCT00080223
Sponsor
Genentech, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Pulmonary FibrosisPulmonary Fibrosis
Start date
2003-08-31
Primary completion
2015-04-30
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.